Last update: July 21, 2020
Minimal risk for breastfeeding and infant.
It is a staphylococcal penicillinase resistant penicillin.
Oral or intravenous administration every 6 hours.
Like most penicillin-type antibiotics (Nau 1987), excretion into breast milk is clinically non-significant (Muysson 2020, Matsuda 1984). No harmful effects are expected nor reported in infants whose mothers were taking it.
Widely used for treatment of Mastitis since it has an effective activity against staphylococci resistant to benzylpenicillin (Amir 2014 y 2011, Spencer 2008, Nordeng 2003, Bodley 2000).
The possibility of transient gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibiotics should be taken into account (Briggs 2017, Ito 1993).
We do not have alternatives for Dicloxacillin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM